Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
TEL AVIV, Israel, Aug. 16, 2017 /PRNewswire/ -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV) (TASE: KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported financial results for the first half of 2017, ending June 30, 2017."We are pleased...
Read more »